We use human data and AI to develop better drugs faster.
Company is active
Event Year: 2015
Company is active
Event Year: 2015
Verge Genomics is revolutionizing drug discovery by leveraging the power of artificial intelligence and comprehensive human data. Their end-to-end, technology-driven platform integrates one of the most extensive proprietary patient genomics datasets derived from human tissue. By applying advanced machine learning techniques to this rich data, Verge Genomics identifies key insights and translates them into novel drug candidates through their innovative human-centric biology and chemistry platforms. This approach aims to accelerate the development of more effective therapeutics.
Verge Genomics is revolutionizing drug discovery by leveraging the power of artificial intelligence and comprehensive human data. Their end-to-end, technology-driven platform integrates one of the most extensive proprietary patient genomics datasets derived from human tissue. By applying advanced machine learning techniques to this rich data, Verge Genomics identifies key insights and translates them into novel drug candidates through their innovative human-centric biology and chemistry platforms. This approach aims to accelerate the development of more effective therapeutics.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2015
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2015
Healthcare
Healthcare
Healthcare -> Drug Discovery and Delivery
Healthcare -> Drug Discovery and Delivery
Team size: 50
Hiring: Yes
Team size: 50
Hiring: Yes
